Search research articles
Contact Us
Filters
Showing results (51-60 of 88) with videos related to
Page
of 9
Sort By:
Blood
|
March 18, 2010
AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit
Tzu-Yin Lin, Joelle Fenger, Sridhar Murahari, et al.
Journal of the American Animal Hospital Association
|
November 13, 2013
Postoperative adjuvant combination therapy with doxorubicin and noncytotoxic suramin in dogs with appendicular osteosarcoma
Francisco J Alvarez, William Kisseberth, Kenji Hosoya, et al.
Veterinary and Comparative Oncology
|
May 3, 2016
Non-immunosuppressive FTY720-derivative OSU-2S mediates reactive oxygen species-mediated cytotoxicity in canine B-cell lymphoma
R Mani, R Yan, X Mo, et al.
Journal of Drug Targeting
|
January 1, 1994
Current studies of liposome muramyl tripeptide (CGP 19835A lipid) therapy for metastasis in spontaneous tumors: a progress review
E G MacEwen, I D Kurzman, S Helfand, et al.
Genes, Chromosomes & Cancer
|
August 13, 2011
Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart
Andrea Y Angstadt, Alison Motsinger-Reif, Rachael Thomas, et al.
BMC Cancer
|
October 12, 2016
MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines
Joelle M Fenger, Ryan D Roberts, O Hans Iwenofu, et al.
Cancer Biotherapy
|
January 1, 1995
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of feline mammary adenocarcinoma--a multicenter randomized double-blind study
L E Fox, E G MacEwen, I D Kurzman, et al.
BMC Cancer
|
March 30, 2011
The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines
Stacey L Fossey, Misty D Bear, Jiayuh Lin, et al.
Veterinary and Comparative Oncology
|
January 31, 2009
NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imaging
M V P Nadella, W C Kisseberth, K S Nadella, et al.
Veterinary and Comparative Oncology
|
May 25, 2021
A retrospective analysis of 11 dogs with surface osteosarcoma
Matthew R Cook, Joshua Lorbach, Brian D Husbands, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 88) with videos related to
Sort By:
Page
of 9
Blood
|
March 18, 2010
AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit
Tzu-Yin Lin, Joelle Fenger, Sridhar Murahari, et al.
Journal of the American Animal Hospital Association
|
November 13, 2013
Postoperative adjuvant combination therapy with doxorubicin and noncytotoxic suramin in dogs with appendicular osteosarcoma
Francisco J Alvarez, William Kisseberth, Kenji Hosoya, et al.
Veterinary and Comparative Oncology
|
May 3, 2016
Non-immunosuppressive FTY720-derivative OSU-2S mediates reactive oxygen species-mediated cytotoxicity in canine B-cell lymphoma
R Mani, R Yan, X Mo, et al.
Journal of Drug Targeting
|
January 1, 1994
Current studies of liposome muramyl tripeptide (CGP 19835A lipid) therapy for metastasis in spontaneous tumors: a progress review
E G MacEwen, I D Kurzman, S Helfand, et al.
Genes, Chromosomes & Cancer
|
August 13, 2011
Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart
Andrea Y Angstadt, Alison Motsinger-Reif, Rachael Thomas, et al.
BMC Cancer
|
October 12, 2016
MiR-9 is overexpressed in spontaneous canine osteosarcoma and promotes a metastatic phenotype including invasion and migration in osteoblasts and osteosarcoma cell lines
Joelle M Fenger, Ryan D Roberts, O Hans Iwenofu, et al.
Cancer Biotherapy
|
January 1, 1995
Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of feline mammary adenocarcinoma--a multicenter randomized double-blind study
L E Fox, E G MacEwen, I D Kurzman, et al.
BMC Cancer
|
March 30, 2011
The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines
Stacey L Fossey, Misty D Bear, Jiayuh Lin, et al.
Veterinary and Comparative Oncology
|
January 31, 2009
NOD/SCID mouse model of canine T-cell lymphoma with humoral hypercalcaemia of malignancy: cytokine gene expression profiling and in vivo bioluminescent imaging
M V P Nadella, W C Kisseberth, K S Nadella, et al.
Veterinary and Comparative Oncology
|
May 25, 2021
A retrospective analysis of 11 dogs with surface osteosarcoma
Matthew R Cook, Joshua Lorbach, Brian D Husbands, et al.
Page
of 9